EGFR and non-small cell lung carcinoma: PC9 cells are highly sensitive to EGFR TKI and are frequently used as a model for studying the resistance of NSCLC to EGFR TKI (Della Corte et al, 2018; Taniguchi et al, 2019; Vojnic et al, 2019; Lin et al, 2023).